Your new experience awaits. Try the new design now and help us make it even better

STUDY PROTOCOL article

Front. Med.

Sec. Rheumatology

This article is part of the Research TopicTherapeutic Strategies: Rehabilitation, Complementary and Alternative Therapies for Musculoskeletal DiseasesView all 4 articles

Opposing Needling in the treatment of Knee Osteoarthritis: An Improved Study Protocol for a Randomized Controlled Trial

Provisionally accepted
Huiying  LiHuiying Li1Siyu  QianSiyu Qian1Xi  WuXi Wu1*Tingting  LuoTingting Luo1*Yanqin  LiuYanqin Liu2Yan  GuoYan Guo3xiaoqin  qin Chenxiaoqin qin Chen2Yao  HuYao Hu3Qiyue  FuQiyue Fu3Qing  LiQing Li3Yuting  XiangYuting Xiang3Ying  LiuYing Liu3
  • 1Chengdu University of Traditional Chinese Medicine, Chengdu, China
  • 2Chengdu Pidu District Hospital of Traditional Chinese Medicine, Chengdu, China
  • 3The Thirteenth People's Hospital of Chongqing, Chongqing, China

The final, formatted version of the article will be published soon.

Background: Knee osteoarthritis (KOA) is a common degenerative joint disease that typically affects individuals over 40 years of age and is characterized by knee pain, stiffness, and functional impairment. Current treatment options, including basic care, pharmacologic therapy, and surgery, often provide limited pain relief or are associated with adverse effects, high costs, and surgical risks. Acupuncture has been conditionally recommended by international guidelines for KOA management and has shown beneficial effects in alleviating pain and improving function. However, most studies have investigated single modalities such as manual acupuncture or electroacupuncture, leaving opportunities to explore strategies that may further enhance therapeutic outcomes. Opposing needling, a classical technique involving contralateral point selection, has demonstrated superior analgesic effects in various chronic pain conditions and is increasingly applied in KOA. Methods: This two-center randomized controlled trial will enroll 108 eligible patients with KOA, who will be randomly assigned in a 1:1:1 ratio to opposing needling plus electroacupuncture, sham opposing needling plus electroacupuncture, or electroacupuncture alone. The 12-week study comprises an 8-week intervention period and a 4-week follow-up, with treatments administered three times per week. The primary outcome will be the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), while secondary outcomes will include WOMAC subscales, Visual Analogue Scale, Numeric Rating Scale, Global Pain Scale, Lequesne Index, Knee Injury and Osteoarthritis Outcome Score, and Short Form-36 Health Survey. Discussion: The findings are expected to provide robust evidence regarding the efficacy and safety of opposing needling as an adjunctive therapy for KOA and to inform optimized treatment strategies. Clinical trial registration: International Traditional Medicine Clinical Trial Registry (itmctr.ccebtcm.org.cn), ITMCTR2025001291.

Keywords: Knee, Osteoarthritis, Opposing Needling, Electroacupuncture, randomized controlled trial, Evidence-based Chinese medicine

Received: 04 Sep 2025; Accepted: 04 Nov 2025.

Copyright: © 2025 Li, Qian, Wu, Luo, Liu, Guo, Chen, Hu, Fu, Li, Xiang and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Xi Wu, wuxi@cdutcm.edu.cn
Tingting Luo, 1970001905@qq.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.